Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
School of Medicine
The Latest
Longitudinal Study of Brain Aging and Cognitive Change Receives $19 Million Grant
Researchers at UC San Diego School of Medicine, with colleagues elsewhere, will receive almost $19 million over five years for the fourth phase of the Vietnam Era Twin Study of Aging, which investigates cognition, aging and the risk for mild cognitive impairment and Alzheimer’s disease.
Putting ‘Super’ in Natural Killer Cells
Using induced pluripotent stem cells (iPSCs) and deleting a key gene, researchers at University of California San Diego School of Medicine have created natural killer cells — a type of immune cell — with measurably stronger activity against a form of leukemia, both in vivo and in vitro.
Your Brain Needs to Be Ready to Remember?
What happens in the hippocampus even before people attempt to form memories may impact whether they remember. Study suggests ‘encoding mode’ may play an important role in memory formation.
Fighting COVID-19 with Knowledge Graphs
The National Science Foundation awards two SDSC researchers funding to organize COVID-19 information into a knowledge network that integrates health, pathogen, and environmental data to track cases across greater San Diego.
Mobile Life Support Delivered to Area Hospitals During COVID-19 Pandemic
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
Trending Stories
In the Media
New UCSD eye research center a son’s visionary tribute to a father’s legacy
The San Diego Union-Tribune, June 23
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
